Skip to content

Sections
- Health
- Pharma
- Biotech
- Hospitals
- Politics
- In the Lab
- First Opinion
- Gut Check
- The Watchdogs
Topics
- Cancer
- Concussions
- CRISPR
- Drug Pricing
- End of Life
- Health Disparities
- Immigration
- Opioids
- Trump
- Women’s Health
- Zika
Multimedia
Popular
STAT Plus

Job Board
About

Newsletters
My Account
- Settings
- Log Out

Newsletters
My Account
- Settings
- Log Out

Alzheimer’s

Biotech

In small Alzheimer’s study, hints of modest benefit from unusual drug

By Sharon Begley

Pharmalot

Pharmalot, Pharmalittle: Former compounder told staff to stop ‘fudging’ after meningitis outbreak

By Ed Silverman

advertisement

Pharmalot

Lilly cuts 200 R&D jobs, but insists an Alzheimer’s failure is not the cause

By Ed Silverman

advertisement

Signal Podcast

Episode 19: From poop transplants to pill politics, here’s the year in ‘Signal’

By Luke Timmerman and Meg Tirrell

Pharmalot

Pharmalot, Pharmalittle: Handful of doctors responsible for high levels of fentanyl prescriptions

By Ed Silverman

Health

Dramatic decline in dementia seen among older adults in the US

By Sharon Begley

Health

Loneliness is bad for your health. This new campaign aims to curb isolation

By Judith Graham

advertisement

In the Lab

Their brains had the telltale signs of Alzheimer’s. So why did they still have nimble minds?

By Sharon Begley

advertisement

Politics

Alzheimer’s is eroding his memory, but not his determination to vote

By Rebecca Robbins

Pharmalot

Pharmalot, Pharmalittle: Valeant sued by Sprout investors over female libido pill

By Ed Silverman

Business

Genetic tests promised to help me achieve peak fitness. What I got was a fiasco

By Rebecca Robbins

Gut Check

Can curcumin spice treat Alzheimer’s disease?

By Sharon Begley

In the Lab

MIT’s Susan Lindquist, a pioneer in science, dies at 67

By Bryan Marquard — Boston Globe

Pharmalot

Pharmalot, Pharmalittle: New bill would create review board for drug prices

By Ed Silverman

Business

A big Alzheimer’s drug trial now wrapping up could offer real hope — or crush it

By Damian Garde

In the Lab

Peter Walter discovered a molecule that makes mice smarter. Can it heal a human brain?

By Usha Lee McFarling

Pharmalot

Pharmalot, Pharmalittle: FDA fast tracks Biogen drug for Alzheimer’s

By Ed Silverman

Health

Gene Wilder died of Alzheimer’s. His family explains why they didn’t disclose his diagnosis

By Dylan Scott

Endnotes

How do you honor a dementia patient’s end-of-life-wishes?

By Bob Tedeschi

Business

Athletes are keeping their distance from a genetic test for concussion risks

By Rebecca Robbins

First Opinion

Stop undertreating Alzheimer’s disease

By Gary W. Small

In the Lab

Alzheimer’s researchers seethe over years of missteps after latest drug failure

By Sharon Begley

Biotech

Promising Alzheimer’s treatment flops in new trial, crushing hopes

By Damian Garde

Health

$75 for reminders to eat: Alzheimer’s patients face flurry of fees while waiting for specialized care

By Megan Thielking

Health

Play on! In a first, brain training cuts risk of dementia 10 years later

By Sharon Begley

Politics

Senate panel set to approve $2 billion NIH funding increase

By David Nather

Business

With its stem cell therapies a bust, pioneering California company to shut down

By Meghana Keshavan

First Opinion

I swallowed my pride and went to a geriatrician. I’m glad I did

By Jane Gross

Health

Reagan Alzheimer’s comedy raises the question: Can illness be funny?

By Dylan Scott

Sign up for our biotech newsletter, The Readout

A guide to what’s new in biotech — delivered straight to your inbox every weekday morning.

Sign up for our morning rounds newsletter

Reporting from the frontiers of health and medicine

About
Contact Us
The STAT Team
Work at STAT
Job Board
Advertise

Privacy
Comment Policy
Terms

© 2017 STAT